Table 1.
Demographics of 14 Adult Patients With CHD2 Variants and Their Genetic Profiles (n = 14)
Patient # | Age range (y) | Family history | Exon # | cDNA | Protein consequence | Variant type | Inheritance | ACMG interpretation | Variant previously reported? |
1 | 18–25 | No | N/A | 93306085_93529447del | 223.362 kbp | Deletion | De novo | Pathogenic | No |
2 | 18–25 | No | 21 | c.2674delC | p.Gln892fs*19 | Frameshift | De novo | Pathogenic | No |
3 | 26–30 | No | 19 | c.2397_2398delTG | p.Leu800Aspfs*25 | Frameshift | De novo | Pathogenic | No |
4 | 18–25 | No | 19 | c.2423_2424insAT | p.Asn808Lysfs*11 | Frameshift | De novo | Likely pathogenic | No |
5 | 18–25 | No | 17 | c.2087delT | p.Phe696Serfs*38 | Frameshift | Parents not tested | Likely pathogenic | No |
6 | 30+ | No | 19 | c.2416_2417dupAG | p.Asn808Glyfs*11 | Frameshift | De novo | Pathogenic | No |
7 | 18–25 | Yes | 38 | c.4968dup | p.Trp1657Metfs*10 | Frameshift | De novo | Pathogenic | Suls et al. (2013) |
8 | 18–25 | No | 32 | c.4133T > G | p.Val1378Gly | Missense | De novo | Likely pathogenic | No |
9 | 18–25 | No | 21 | c.2636C > T | p.Ala879Val | Missense | De novo | Pathogenic | No |
10 | 18–25 | No | 26 | c.3298G > A | p.Ala1100Thr | Missense | De novo | Likely pathogenic | No |
11 | 26–30 | No | 36 | c.4602G > T | p.Trp1534Cys | Missense | De novo | Likely pathogenic | No |
12 | 30+ | No | 17 | c.2095C > T | p.Arg699Trp | Missense | De novo | Pathogenic | De Maria et al. (2022) |
13 | 18–25 | No | 38 | c.4909C > T | p.Arg1637* | Nonsense | De novo | Pathogenic | Suls et al. (2013); Carvill et al. (2013); Galizia et al. (2015) |
14 | 18–25 | No | 8 | c.789dupT | p.Glu264* | Nonsense | De novo | Likely pathogenic | No |
Abbreviations: ASD = autism spectrum disorder; F = female; M = male.
Sex, age, ASD diagnosis, family history of epilepsy, and ethnicity are listed when provided. The zygosity of all variants was heterozygous.